↓ Skip to main content

Dove Medical Press

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
16 Mendeley
Title
Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
Published in
Neuropsychiatric Disease and Treatment, September 2013
DOI 10.2147/ndt.s50135
Pubmed ID
Authors

Osamu Kano, Yoshihisa Urita, Hirono Ito, Takanori Takazawa, Yuji Kawase, Kiyoko Murata, Takehisa Hirayama, Ken Miura, Yuichi Ishikawa, Tetsuhito Kiyozuka, Jo Aoyagi, Yasuo Iwasaki

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 13%
Student > Master 2 13%
Researcher 2 13%
Student > Bachelor 1 6%
Unspecified 1 6%
Other 2 13%
Unknown 6 38%
Readers by discipline Count As %
Neuroscience 2 13%
Medicine and Dentistry 2 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Nursing and Health Professions 1 6%
Other 3 19%
Unknown 6 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2013.
All research outputs
#16,046,765
of 25,371,288 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,583
of 3,132 outputs
Outputs of similar age
#123,070
of 212,462 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#30
of 67 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,462 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.